Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TC-325 vs Standard Treatment in Acute Upper GI Bleeding
NCT02534571Phase 3Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Sep 2015
- Primary completion
- Jan 2019
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in upper gastrointestinal bleeding (UGIB), sponsored by The Chinese University of Hong Kong. Primary endpoint: Recurrent upper gastro-intestinal bleeding at 30 days. Started Sep 2015; status: completed.
02
Conditions
upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on NCT02534571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02534571.